Prescription Drug Information: Capecitabine 150mg (Page 11 of 11)

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

image description
(click image for full-size original)

image description
(click image for full-size original)
CAPECITABINE 150MG capecitabine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72606-554
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CAPECITABINE (CAPECITABINE) CAPECITABINE 150 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
MAGNESIUM STEARATE
WATER
TITANIUM DIOXIDE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
TALC
Product Characteristics
Color pink (Light pink) Score no score
Shape capsule (Capsule shaped biconvex) Size 11mm
Flavor Imprint Code CAP;150
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72606-554-01 60 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207456 11/06/2019
CAPECITABINE 500MG capecitabine tablet, film coated
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72606-555
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CAPECITABINE (CAPECITABINE) CAPECITABINE 500 mg
Inactive Ingredients
Ingredient Name Strength
ANHYDROUS LACTOSE
CROSCARMELLOSE SODIUM
HYPROMELLOSE, UNSPECIFIED
MICROCRYSTALLINE CELLULOSE
MAGNESIUM STEARATE
WATER
TITANIUM DIOXIDE
FERRIC OXIDE RED
FERRIC OXIDE YELLOW
TALC
Product Characteristics
Color pink (Dark Pink) Score no score
Shape capsule (Capsule shaped biconvex) Size 16mm
Flavor Imprint Code CAP;500
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:72606-555-01 120 TABLET, FILM COATED in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA207456 11/06/2019
Labeler — CELLTRION USA, INC. (116587378)
Establishment
Name Address ID/FEI Operations
Shilpa Medicare Ltd. 650644136 manufacture (72606-554), manufacture (72606-555)

Revised: 11/2019 CELLTRION USA, INC.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2019. All Rights Reserved.